INCY vs MRK · P/E 14, rev $5.14B vs P/E 33, rev $16.61B
Incyte Corporation (INCY) versus Merck & Company Inc (MRK) — a side-by-side from cached financials, not a winner call.
Incyte Corporation (INCY) is a biotechnology company listed on US.
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Robert M. Davis J.D..
Latest reported INCY revenue for 2025-12-31 was $5.14B. Net income was $1.29B. Revenue was up 21.2% from 2024-12-31 to 2025-12-31. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
Latest reported MRK revenue for 2026-06-30 was $16.61B. Net income was -$1.33B. Revenue was up 2.0% from 2026-03-31 to 2026-06-30. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
INCY currently screens at market cap $20.45B and trailing P/E 14.5. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
Not investment advice. Open the INCY and MRK stock pages for the full models.
Not investment advice.